tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

KALV Stock Latest News

KalVista Pharmaceuticals: Promising Market Prospects for Sebetralstat with Imminent FDA Approval
RatingsKalVista Pharmaceuticals: Promising Market Prospects for Sebetralstat with Imminent FDA Approval
13h ago
KALV
KalVista completes enrollment in KONFIDENT-KID clinical trial of sebetralstat
PremiumThe Fly
KalVista completes enrollment in KONFIDENT-KID clinical trial of sebetralstat
17h ago
KALV
Buy Rating for KalVista Pharmaceuticals Driven by Strategic Positioning and Market Potential of Sebetralstat
PremiumRatings
Buy Rating for KalVista Pharmaceuticals Driven by Strategic Positioning and Market Potential of Sebetralstat
9d ago
KALV
Buy Rating for KalVista Pharmaceuticals: Strong Regulatory Progress and Market Potential for Sebetralstat
PremiumRatings
Buy Rating for KalVista Pharmaceuticals: Strong Regulatory Progress and Market Potential for Sebetralstat
9d ago
KALV
Promising Potential of Sebetralstat: A Game-Changer in Hereditary Angioedema Treatment
PremiumRatings
Promising Potential of Sebetralstat: A Game-Changer in Hereditary Angioedema Treatment
12d ago
KALV
Buy Rating for KalVista Pharmaceuticals Driven by Anticipated FDA Approval and Strong Market Position
PremiumRatingsBuy Rating for KalVista Pharmaceuticals Driven by Anticipated FDA Approval and Strong Market Position
13d ago
KALV
KalVista Pharmaceuticals Advances Sebetralstat for HAE
Premium
Company Announcements
KalVista Pharmaceuticals Advances Sebetralstat for HAE
13d ago
KALV
KalVista Pharmaceuticals: Strategic Preparations and Financial Strength Underpin Buy Rating Amid Anticipated Sebetralstat Approval
Premium
Ratings
KalVista Pharmaceuticals: Strategic Preparations and Financial Strength Underpin Buy Rating Amid Anticipated Sebetralstat Approval
14d ago
KALV
Buy Rating for KalVista Pharmaceuticals Driven by Strong Financials and Promising Ekterly Launch
PremiumRatings
Buy Rating for KalVista Pharmaceuticals Driven by Strong Financials and Promising Ekterly Launch
14d ago
KALV
Morning Movers: iRobot plunges following Q4 results
PremiumThe Fly
Morning Movers: iRobot plunges following Q4 results
14d ago
MX
ABM
KalVista reports Q3 EPS (92c), consensus (87c)
PremiumThe Fly
KalVista reports Q3 EPS (92c), consensus (87c)
14d ago
KALV
KALV Earnings this Week: How Will it Perform?
PremiumPre-Earnings
KALV Earnings this Week: How Will it Perform?
16d ago
KALV
KalVista Pharmaceuticals’ Sebetralstat: A Game-Changer in Oral HAE Treatment with Strong Market Potential
PremiumRatingsKalVista Pharmaceuticals’ Sebetralstat: A Game-Changer in Oral HAE Treatment with Strong Market Potential
23d ago
KALV
KalVista initiated with an Outperform at JMP Securities
Premium
The Fly
KalVista initiated with an Outperform at JMP Securities
2M ago
KALV
KalVista granted orphan drug designation for sebetralstat by MHLW
Premium
The Fly
KalVista granted orphan drug designation for sebetralstat by MHLW
2M ago
KALV
KalVista initiated with a Buy at TD Cowen
PremiumThe Fly
KalVista initiated with a Buy at TD Cowen
3M ago
KALV
KalVista initiated with a Buy at BofA
PremiumThe Fly
KalVista initiated with a Buy at BofA
3M ago
KALV
KalVista Pharmaceuticals Appoints New COO Amid Strategic Growth
PremiumCompany Announcements
KalVista Pharmaceuticals Appoints New COO Amid Strategic Growth
3M ago
8K
KALV
KalVista appoints Jeb Ledell as COO
PremiumThe Fly
KalVista appoints Jeb Ledell as COO
3M ago
KALV
KalVista price target lowered to $33 from $35 at JonesResearch
PremiumThe FlyKalVista price target lowered to $33 from $35 at JonesResearch
4M ago
KALV
KalVista Pharmaceuticals Reports Progress in HAE Treatment
Premium
Company Announcements
KalVista Pharmaceuticals Reports Progress in HAE Treatment
4M ago
KALV
KalVista reports Q2 EPS (91c), consensus (91c)
Premium
The Fly
KalVista reports Q2 EPS (91c), consensus (91c)
4M ago
KALV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >